B. Braun Medical Limited Sustainability Profile
B. Braun Medical Limited, a prominent player in the healthcare industry, is headquartered in Great Britain and operates extensively across Europe, Asia, and the Americas. Founded in 1839, the company has established itself as a leader in medical technology, focusing on areas such as infusion therapy, pain management, and surgical instruments. With a commitment to innovation, B. Braun offers a diverse range of core products, including intravenous solutions, catheters, and surgical sutures, all designed to enhance patient safety and improve clinical outcomes. The company is recognised for its dedication to quality and sustainability, positioning itself as a trusted partner in healthcare. B. Braun's notable achievements include numerous awards for excellence in medical technology and a strong market presence, making it a key contributor to advancements in patient care worldwide.
DitchCarbon Score
How does B. Braun Medical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
B. Braun Medical Limited's score of 21 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
B. Braun Medical Limited's reported carbon emissions
B. Braun Medical Limited, headquartered in Great Britain, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is a current subsidiary of B. Braun Holding GmbH & Co. KG, which may influence its overall climate strategy and commitments. As of now, B. Braun Medical Limited has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of data suggests that the company may still be in the early stages of developing its climate commitments or reporting frameworks. In the context of the medical technology industry, companies are increasingly expected to adopt robust sustainability practices and set measurable targets for reducing greenhouse gas emissions across all scopes (Scope 1, 2, and 3). However, without specific commitments or data from B. Braun Medical Limited, it is challenging to assess their current standing in relation to industry standards. Overall, while B. Braun Medical Limited is part of a larger corporate family that may have established climate initiatives, the absence of detailed emissions data and reduction targets limits the ability to evaluate their environmental impact and commitments effectively.
How Carbon Intensive is B. Braun Medical Limited's Industry?
How Carbon Intensive is B. Braun Medical Limited's Location?
B. Braun Medical Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
B. Braun Medical Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
